ArticleThe Lancet. Rheumatology2020
Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection.
Article in The Lancet. Rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- COVID-associated arthritis after severe and non-severe COVID-19: A systematic review.Immunity, inflammation and disease · 2023Pooled it
- Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.Frontiers in immunologyPooled it
- Rheumatoid Arthritis Development following COVID-19 Infection: Eighth Case Described.Mediterranean journal of rheumatology · 2024Article
- COVID-19 with Suspected Secondary Pyogenic Arthritis of the Hip: A Case Report and Literature Review.Journal of orthopaedic case reports · 2024Article
- Covid-19-related right hip monoarthritis: A case report and literature review.Clinical case reports · 2024Article
- Molecular mimicry and autoimmunity in the time of COVID-19.Journal of autoimmunity · 2023Review
- Acute arthritis following SARS-CoV-2 infection: About two cases.Clinical case reports · 2023Article
- Review
- Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.Viruses · 2023Review
- Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study.Frontiers in medicine · 2023Article
- COVID-19 and the antiphospholipid syndrome.Autoimmunity reviews · 2022Review
- A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection.Clinical immunology communications · 2022Article
- COVID-19-associated arthritis: an emerging new entity?RMD open · 2022Review
- Reactive arthritis before and after the onset of the COVID-19 pandemic.Clinical rheumatology · 2022Review
- Can SARS-CoV-2 infection trigger rheumatoid arthritis? A case report.Clinical case reports · 2022Article
- Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection.Internal medicine (Tokyo, Japan) · 2022Article
- The role of B cells in COVID-19 infection and vaccination.Frontiers in immunology · 2022Review
- SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.Journal of translational autoimmunity · 2022Article
- IFI44 is an immune evasion biomarker for SARS-CoV-2 andFrontiers in immunology · 2022Article
- SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.Frontiers in immunology · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.